Multiple genetic variants at the SLC30A8 locus affect local super-enhancer activity and influence pancreatic β cell survival and function
Hu, M.; Kim, I.; Moran, I.; Peng, W.; Sun, O.; Bonnefond, A.; Khamnis, A.; Bonas-Guarch, S.; Froguel, P.; Rutter, G. A.
Show abstract
Variants at the SLC30A8 locus are associated with type 2 diabetes (T2D) risk. The lead variant, rs13266634, encodes an amino acid change, Arg325Trp (R325W), at the C-terminus of the secretory granule-enriched zinc transporter, ZnT8. Although this protein-coding variant was previously thought to be the sole driver of T2D risk at this locus, recent studies have provided evidence for lowered expression of SLC30A8 mRNA in protective allele carriers. In the present study, combined allele-specific expression (cASE) analysis in human islets revealed multiple variants that influence SLC30A8 expression. Epigenomic mapping identified an islet-selective enhancer cluster at the SLC30A8 locus, hosting multiple T2D risk and cASE associations, which is spatially associated with the SLC30A8 promoter and additional neighbouring genes. Deletions of variant-bearing enhancer regions using CRISPR-Cas9 in human-derived EndoC-{beta}H3 cells lowered the expression of SLC30A8 and several neighbouring genes, and improved insulin secretion. Whilst down-regulation of SLC30A8 had no effect on beta cell survival, loss of UTP23, RAD21 or MED30 markedly reduced cell viability. Although eQTL or cASE analyses in human islets did not support the association between these additional genes and diabetes risk, the transcriptional regulator JQ1 lowered the expression of multiple genes at the SLC30A8 locus and enhanced stimulated insulin secretion.
Matching journals
The top 4 journals account for 50% of the predicted probability mass.
Similar papers in this journal
- Differential CpG methylation at Nnat in the early establishment of beta cell heterogeneity 95%
- High-throughput Genetic Clustering of Type 2 Diabetes Loci Reveals Heterogeneous Mechanistic Pathways of Metabolic Disease 95%
- The power of TOPMed imputation for the discovery of Latino enriched rare variants associated with type 2 diabetes 94%
Similar papers in this journal
- Extensive NEUROG3 occupancy in the human pancreatic endocrine gene regulatory network 96%
- Cyb5r3 links FoxO1-dependent mitochondrial dysfunction with β-cell failure 95%
- The type 2 diabetes gene product STARD10 is a phosphoinositide binding protein that controls insulin secretory granule biogenesis 94%
Similar papers in this journal
- Liraglutide treatment reverses unconventional cellular defects in induced pluripotent stem cell-derived β cells harboring a partially functional WFS1 variant 95%
- Furin controls β cell function via mTORC1 signaling 94%
- Pancreatic β-cell specific loss of E2f1 impairs insulin secretion and β-cell identity through the epigenetic repression of non β-cell programs 94%
Similar papers in this journal
- A signature of Neanderthal introgression on molecular mechanisms of environmental responses 92%
- Mesenchymal Igf2 is a major paracrine regulator of pancreatic growth and function 92%
- Lipidomic QTL in Diversity Outbred mice identifies a novel function for α/β hydrolase domain 2 (Abhd2) as an enzyme that metabolizes phosphatidylcholine and cardiolipin 92%
Similar papers in this journal
- The Cardiolipin Transacylase Tafazzin Regulates Basal Insulin Secretion and Mitochondrial Function in Pancreatic Islets from Mice 94%
- Small molecule-mediated insulin hypersecretion induces transient unfolded protein response and loss of beta cell function 92%
- Differential effects of voclosporin and tacrolimus on insulin secretion from human islets 92%
"Similar papers" are the closest papers from that journal in the model's embedding space. They show what the match is built on, but the ranking comes mostly from a classifier over the whole training set, not from these examples alone.